How to switch from Abilify Maintena to Aristada?

Abilify Maintena (aripiprazole) and Aristada (aripiprazole lauroxil) contain an atypical antipsychotic. They are both used to treat adults with schizophrenia.

Aristada contains aripiprazole lauroxil - a prodrug of aripiprazole - which is the active ingredient in Abilify Maintena. When patients take Aristada, aripiprazole lauroxil is converted to aripiprazole by the body.

Abilify Maintena and Aristada are extended release (depot) injections that are administered by a healthcare professional into the patient’s deltoid or gluteal muscle.

Switching from Abilify Maintena to Aristada

The recommended starting and maintenance dose of Abilify Maintena is 400mg a month. It takes four doses to reach steady state concentrations of the drug - for the amount of the drug being absorbed to match the amount being cleared from the body.

Patients stabilized on Abilify Maintena 400 mg a month who have reached steady state concentrations can be switched to Aristada 882 mg four weeks after their last Abilify Maintena 400 mg intramuscular injection.

Why switch from Abilify Maintena to Aristada?

Although they both contain aripiprazole, sometimes people will need to switch from Abilify Maintena to Aristada because of:

• Insurance plan coverage
• Needing a long acting injectable medication. Abilify Maintena is administered monthly, but Aristada can be administered monthly, every six weeks or every two months.